# Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine

> **NCT01367808** · PHASE1 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine

## Interventions

- **DRUG:** Placebo
- **DRUG:** vorikonazole
- **DRUG:** posakonazole

## Key facts

- **NCT ID:** NCT01367808
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367808, "Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01367808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
